See the latest news and media coverage for Manas. We track all announcements, press releases, and industry mentions in real time, all in one place.
AI-native biopharmaceutical company
manasai.coLast updated
In short: Manas AI, cofounded by Reid Hoffman, raised over $50 million and forged drug-discovery partnerships.
The deal grants deep access to Schrödinger’s physics-based platform, expert support, and integration to enhance AI-driven drug discovery. CEO Siddhartha Mukherjee highlights competitive advantage.
Jonathan Baell brings over 20 years of medicinal chemistry experience to lead scientific strategy and research at Manas AI.
The company raised funds to accelerate foundational models, advance therapeutic campaigns, and expand its interdisciplinary team, welcoming Ujjwal Singh as co-founder and CTO.
Reid Hoffman raised $24.6 million for an AI cancer research startup featured by Manas AI in the Wall Street Journal on January 27, 2025.
Reid Hoffman, co-founder of LinkedIn, has announced his departure from the board of directors of Microsoft, LinkedIn's parent company, to focus on developing his...
Market Volatility Management- Join our fast-growing stock community and gain access to exclusive investing benefits including daily stock picks, earnings tracking, risk management tools, and...
Investment Advice Group - Assess leadership quality with comprehensive analysis. LinkedIn co-founder Reid Hoffman and renowned oncologist Siddhartha Mukherjee have secured $24.6 million to launch...
Learn from experts and develop winning strategies with our comprehensive educational resources and market insights designed for all levels. LinkedIn co-founder Reid Hoffman has raised...
Track Manas and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Manas and other trending companies.
